BioLife Solutions (BLFS) Financial Statements & Analysis

BioLife Solutions (BLFS) Income Statement

BioLife Solutions reported revenue of $96.21M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 28.9% from $74.65M a year earlier. BioLife Solutions posted a net loss of $12.13M, compared with a net loss of $20.18M a year earlier. Gross margin was 64.6% and operating margin -1.1%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $28.47M, up 12.0% from the same quarter a year earlier.

BioLife Solutions Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

BioLife Solutions, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	96.21	74.65	68.02	76.24	119.16	48.09	27.37	19.74	11.02
Cost of Revenue	34.10	24.55	26.70	29.33	82.11	20.24	9.84	6.22	4.28
Gross Profit	62.12	50.10	41.32	46.91	37.05	27.85	17.53	13.53	6.75
Operating Expenses
Research & Development	7.57	4.75	5.52	14.80	11.82	6.72	4.12	1.30	1.19
Selling, General & Administrative	55.37	49.56	54.17	44.93	47.67	21.69	13.59	8.57	6.61
Operating Expenses	62.94	54.57	60.72	52.83	67.70	31.44	19.12	9.86	7.80
Operating Income	-1.08	-4.48	-19.40	-5.92	-30.65	-3.59	-0.22	3.66	-1.06
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00	0.04	0.51	0.28	0.00
Interest Expense	2.71	-0.72	0.00	0.69	-0.49	0.00	0.01	0.01	0.46
Other Income/Expense	-11.00	-2.81	8.58	1.08	2.11	3.60	-2.98	-28.67	-1.46
Income
Income Before Tax	-12.08	-8.82	-12.22	-4.85	-29.03	-1.28	-3.20	-25.01	-2.52
Income Tax Expense	0.05	-0.04	-0.06	-5.24	-20.12	-3.26	-1.54	0.00	0.00
Net Income	-12.13	-20.18	-68.00	-139.81	-8.91	1.98	-1.66	-25.01	-2.52
Net Income - Continuous Operations	-12.13	-8.79	-12.16	-139.81	-8.91	2.67	-1.66	-25.01	-2.52
Net Income - Discontinued Operations	7.54	-11.40	-55.85	-140.19	-	-	-	-	-
EBITDA	3.61	4.18	-7.10	-3.10	-17.78	1.48	2.57	-24.66	-1.79
EBIT	-1.08	-4.48	-19.40	-10.68	-30.65	-3.59	-	-	-
Depreciation & Amortization	4.69	5.49	1.03	7.58	8.20	5.07	1.80	0.34	0.34
Earnings Per Share
Basic EPS	-	-	-2.00	-3.00	-	-	-	-2.00	-
Diluted EPS	-	-	-2.00	-3.00	-	-	-	-2.00	-
Basic Shares Outstanding	47.75	46.07	43.72	42.48	38.50	27.31	19.46	16.26	13.26
Diluted Shares Outstanding	48.65	46.07	43.72	42.48	38.50	27.31	19.46	16.26	13.26

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BioLife Solutions Financial Statements

What was BioLife Solutions's revenue in fiscal 2025?

BioLife Solutions reported revenue of $96.21M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 28.9% from $74.65M a year earlier.

Is BioLife Solutions profitable?

No. BioLife Solutions reported a net loss of $12.13M in fiscal 2025. In fiscal 2024 it lost $20.18M.

What is BioLife Solutions's operating margin?

BioLife Solutions's operating income was −$1.08M on revenue of $96.21M in fiscal 2025, an operating margin of -1.1%, compared with -6.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition